| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1032998763 |
| P356 | DOI | 10.1186/S41256-016-0010-Y |
| P932 | PMC publication ID | 5693550 |
| P698 | PubMed publication ID | 29202059 |
| P50 | author | Olusesan Ayodeji Makinde | Q50278972 |
| P2093 | author name string | Mojisola Ojo | |
| Abimbola Onigbanjo Williams | |||
| P2860 | cites work | Grading quality of evidence and strength of recommendations | Q24562409 |
| Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysis | Q26999537 | ||
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q27860647 | ||
| How should meta-regression analyses be undertaken and interpreted? | Q28193388 | ||
| Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru | Q28202372 | ||
| Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin | Q28265640 | ||
| Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines | Q28469046 | ||
| Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures | Q28469334 | ||
| Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis | Q28476110 | ||
| Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience | Q28478005 | ||
| Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study | Q33586629 | ||
| Dealing with substantial heterogeneity in Cochrane reviews. Cross-sectional study | Q33829273 | ||
| Community based interventions for the prevention and control of tuberculosis | Q34059811 | ||
| MDR tuberculosis--critical steps for prevention and control | Q34136765 | ||
| High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003. | Q34423664 | ||
| Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis | Q34952765 | ||
| Increasing transparency in partnerships for health--introducing the Green Light Committee | Q34976025 | ||
| Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India | Q35062842 | ||
| How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. | Q35065178 | ||
| Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa | Q35072895 | ||
| Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa | Q35762608 | ||
| ??? | Q27023413 | ||
| Community-based treatment of multidrug-resistant tuberculosis: early experience and results from Western Kenya. | Q35953915 | ||
| Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care | Q36078264 | ||
| Comprehensive treatment of extensively drug-resistant tuberculosis. | Q37170546 | ||
| Interpretation of tests of heterogeneity and bias in meta-analysis | Q37329334 | ||
| Understanding heterogeneity in meta-analysis: the role of meta-regression | Q37600940 | ||
| A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis | Q37954377 | ||
| Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis | Q38544938 | ||
| Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis | Q39549707 | ||
| Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience. | Q39814578 | ||
| Seven-year DOTS-Plus pilot experience in India: results, constraints and issues | Q39898977 | ||
| Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa | Q40180199 | ||
| Treatment interruption and directly observed treatment of multidrug-resistant tuberculosis patients in China. | Q41092878 | ||
| Decentralised management of drug-resistant tuberculosis (MDR- and XDR-TB) in South Africa: an alternative model of care | Q44436955 | ||
| Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa. | Q46339395 | ||
| Community-based management of multidrug-resistant tuberculosis in South Africa. | Q46576124 | ||
| Home based care to multi-drug resistant tuberculosis patients: A pilot study | Q50898392 | ||
| Assessing publication bias in meta-analyses in the presence of between-study heterogeneity | Q56047275 | ||
| Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) | Q56529840 | ||
| Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study | Q61387558 | ||
| Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands | Q74192079 | ||
| Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia | Q79949193 | ||
| P921 | main subject | inpatient care | Q1431847 |
| P304 | page(s) | 10 | |
| P577 | publication date | 2016-08-02 | |
| P1433 | published in | Global Health Research and Policy | Q50817400 |
| P1476 | title | Community-based management versus traditional hospitalization in treatment of drug-resistant tuberculosis: a systematic review and meta-analysis | |
| P478 | volume | 1 |
Search more.